Advanced Animal Diagnostics

Fund: 2018
Sector: Animal Health

Advanced Animal Diagnostics, Inc. (“AAD”) has developed diagnostic tests to help livestock producers detect diseases and manage the reproductive, nutritional and overall health status of animals.

visit website

AN2 Therapeutics

Fund: 2018
Sector: Life Sciences

AN2 Therapeutics is a clinical-stage biopharmaceutical company focused on novel medicines targeting infectious diseases.

visit website

AngelEye Health

Fund: 2018
Sector: Disruptive Technology

AngelEye Health has developed internet-based camera systems and educational and clinical communications software to transform neonatal care.

visit website

Appello Pharmaceuticals

Fund: 2018
Sector: Life Sciences

Appello Pharmaceuticals is a preclinical-stage company focused on advancing novel positive allosteric modulators of mGlu4 for the treatment of Parkinson’s disease.

visit website

Applied LifeSciences & Systems Poultry

Fund: 2018
Sector: Animal Health

Applied LifeSciences & Systems Poultry (“ALSSP”) is a poultry vaccine delivery device company developing a high-throughput vaccine delivery system to be used in the hatchery to individually vaccinate post-hatch chicks using a novel vaccination spray system.

visit website

Aspire Health

Fund: 2013
Sector: Disruptive Technology

Aspire Health  is a healthcare company that specializes in providing an extra layer of support to patients facing a serious illness. Aspire’s clinicians are experts in providing patients with relief from the symptoms, pain, and stress of a serious illness; helping patients and caregivers navigate the healthcare system; guiding patients and caregivers through difficult and complex treatment choices and providing emotional and spiritual support to patients and their families.

visit website

Boragen

Fund: 2018
Sector: Life Sciences

Boragen is a small molecule development company focused on leveraging the unique chemical properties of Boron chemistry, both in crop protection and animal health.

visit website

Castle Biosciences

Fund: 2013, 2018
Sector: Life Sciences

Castle Biosciences is focused on developing and commercializing molecular diagnostics to aid health care professionals in assessing types and sub-types of tumors. Products focus on differentiating tumor types at the molecular level using various means of analyzing and comparing components of DNA.

visit website

Cerebrotech Medical Systems

Fund: 2013, 2018
Sector: Life Sciences

Cerebrotech Medical Systems has developed a non-invasive, continuous monitor for early detection of cerebral fluid change (primarily edema or bleeding) that can occur in a number of neurologic conditions, including stroke, traumatic brain injury, post brain surgery, etc.

visit website

Clearside Biomedical

Fund: 2013
Sector: Life Sciences

Clearside Biomedical is an ophthalmic company specializing in the research, development and commercialization of therapeutic products delivered through a proprietary microinjection platform that targets the suprachoroidal space in the region of the eye.

visit website

Contego Medical

Fund: 2013
Sector: Life Sciences

Contego Medical has developed a platform based on the integration of an embolic protection filter and a treatment device into a single catheter. By offering embolic protection on the same catheter as a balloon or stent, patients are offered a safer procedure without adding time, complexity, or expense and physicians can perform the procedure in less time.

visit website

Corcept Therapeutics

Fund: Legacy
Sector: Life Sciences

Corcept Therapeutics is a pharmaceutical company engaged in the discovery and development of drugs for the treatment of severe metabolic and psychiatric disorders.

visit website

Diabetes Care Group

Fund: 2013
Sector: Life Sciences

Diabetes Care Group is a healthcare services firm focused on treating diabetes through a proprietary, proven clinical delivery model that aids patients in controlling A1c levels. It’s a Fee-for-Results model that uses subscription-based and results-based bonuses, which allow patients to take advantage of services, such as nutritional counseling, that are typically not reimbursable under most healthcare plans. Since its founding in 2009, DCG has been organizing ideas around bringing diabetes medical management together with intensive, focused diabetes education in one location.

visit website

Diagnovus

Fund: 2013
Sector: Life Sciences

Diagnovus is focused on developing and commercializing molecular diagnostics to aid health care professionals in assessing types and sub-types of tumors. Products focus on differentiating tumor types at the molecular level using various means of analyzing and comparing components of DNA. The Company was acquired by Aegis Sciences Corporation in January 2015.

visit website

Evermind

Fund: 2013
Sector: Disruptive Technology

Evermind improves the lives of those who are living independently or managing a chronic disease, and those who provide care for them, by remotely monitoring the usage of home appliances and home medical equipment.

visit website

Extend Snacks

Fund: Legacy
Sector: Life Sciences

Clinical Products sells under the Extend brand name a line of delicious, convenient snacks that are clinically proven to help stabilize blood sugar for up to 9 hours. Extend Snacks are an excellent snack choice for anyone interested in blood sugar management. The company’s bars, crisps, and shakes are available in multiple flavors and can be purchased online.

visit website

Exubrion

Fund: 2018
Sector: Animal Health

Exubrion Therapeutics is developing a radiosynoviorthesis product to treat chronic osteoarthritis in dogs. The technology was originally developed for human use.

visit website

G1 Therapeutics

Fund: 2013
Sector: Life Sciences

G1 Therapeutics is a clinical-stage company developing small-molecule therapies to address significant unmet needs in oncology. The company is leveraging its proprietary kinase drug discovery platform to advance a pipeline of first-in-class compounds and best-in-class drug candidates.

visit website

In The Bowl

Fund: 2018
Sector: Animal Health

In the Bowl Animal Health is providing pet owners with a creative alternative to current methods of drug administration.

visit website

Ironwood

Fund: Legacy
Sector: Life Sciences

Ironwood Pharmaceuticals is an entrepreneurial pharmaceutical company dedicated to creating, developing, and commercializing innovative human medicines.

visit website

LineaGen

Fund: 2013
Sector: Life Sciences

LineaGen provides chromosomal microarray and next generation sequencing genetic testing for individuals with autism spectrum disorder and other post-natal developmental disorders.  Lineagen also provides both pre- and post-test genetic counseling to assess the impact of the results on the patient and other family members, as well as anticipatory guidance to physicians regarding potential clinical management changes.

visit website

MedCenterDisplay

Fund: 2013
Sector: Disruptive Technology

MedCenterDisplay is commercializing digital health networks in hospitals (and other provider settings) with screens in high wait-time and high traffic areas The Company was acquired by PatientPoint in November 2016.

visit website

Mindera

Fund: 2018
Sector: Life Sciences

Mindera Corporation has developed a proprietary micro biopsy tool used to extract a patient’s transcriptome. After processing via next-generation sequencing and analysis, dermatologists will be able to make personalized diagnoses and track disease progression.

visit website

Myomo

Fund: 2013
Sector: Life Sciences

Myomo is a medical device company that has developed a custom myoelectric elbow orthotic device, enabling individuals afflicted with stroke and other neuromuscular conditions to self-initiate and control movement of a partially paralyzed arm using their own muscle signals.

visit website

NeuroTronik

Fund: 2013
Sector: Life Sciences

NeuroTronik Limited is a medical device company focused on providing hemodynamic management of patients who are admitted with acute heart failure syndrome (“AHFS”). The NeuroTronik technology utilizes a patented intravascular electrode system capable of selectively stimulating parasympathetic and sympathetic nerves simultaneously or in a preferred cadence.

visit website

NuSirt

Fund: 2013
Sector: Life Sciences

NuSirt Sciences is a biotechnology company focused on developing products targeting metabolic diseases associated with over-nutrition such as: obesity, diabetes, and inflammatory stress.

visit website

Odd Networks

Fund: 2013
Sector: Disruptive Technology

Odd Networks is a custom service provider for the distribution of content through interactive media. With decades of experience in the video game and digital media industry working to fundamentally changing the way content is consumed. Odd is composed of digital media experts, as well as creative designers and experienced developers.”

visit website

Orig3n

Fund: 2013
Sector: Disruptive Technology

ORIG3N is biotechnology company looking to develop breakthrough drug efficacy diagnostics for rare genetically inherited diseases with targets in heart, liver and neurodegenerative indications utilizing induced pluripotent stem cells.

visit website

Panopto

Fund: Legacy
Sector: Disruptive Technology

Panopto offers a flexible and easy-to-use presentation capture platform that lets users capture, edit, stream, archive, and share recordings that preserve critical knowledge. This rich media video capture software solution is available as licensed software for enterprises or individuals. It can be installed locally behind an organization’s firewall or accessed online through Panopto servers as part of a hosted service. This flexibility minimizes the technical barriers for adoption and reduces the cost of scaling the solution across an enterprise.

visit website

Pharm MD

Fund: Legacy
Sector: Disruptive Technology

PharmMD offers comprehensive Medication Therapy Management (MTM) services to improve patient outcomes and lower healthcare costs by coordinating healthcare among physicians, pharmacists and patients. The PharmMD program works with a company’s health insurance plan to confidentially review the medical, lab and prescription drug usage of all covered employees and their covered dependents. This secure, comprehensive review helps identify potentially harmful drug interactions, overuse/underuse/misuse of medications and services, and possible generic medication options.

visit website

PhaseBio Pharmaceuticals

Fund: 2018
Sector: Life Sciences

PhaseBio Pharmaceuticals is a clinical-stage biopharmaceutical company committed to developing improved biotherapeutics for the treatment of orphan diseases, with an initial focus on cardiopulmonary indications.

visit website

Preferral

Fund: Legacy
Sector: Disruptive Technology

Preferral is a HIPAA-compliant platform for Referral Management and Online Referral Forms.

visit website

ReVIDA Recovery Centers

Fund: 2018
Sector: Disruptive Technology

ReVIDA Recovery Centers operates seven medication assisted treatment clinics located throughout Tennessee and Virginia to assist opioid addicts in their recovery.

visit website

Silicon Ranch

Fund: 2013, 2018
Sector: Disruptive Technology

Silicon Ranch Corporation is a developer and operator of utility scale solar facilities that provides turn-key renewable energy solutions to industry and utility partners.

visit website

Skyline Vet Pharma

Fund: Legacy
Sector: Animal Health

Skyline Vet Pharma, a specialty veterinary pharmaceutical company, is using proven delivery technologies to reformulate drugs and nutraceuticals with established animal health markets.  As a new animal health product development company employing novel delivery technologies, Skyline is distinguished from its contemporaries by repositioning drugs already used in human and animal health, so avoiding drug discovery.

visit website

SplitSecond

Fund: 2013
Sector: Disruptive Technology

Cyber Physical Systems, also known as SplitSecond, is a consumer product development and service company based in Nashville, TN. The Company develops telematics devices and associated applications that allow consumers and their loved ones to easily upgrade the safety of their vehicles, giving them peace of mind while driving; this is currently only enjoyed by a fraction of the driving public.

visit website

ValuePaymentSystems

Fund: Legacy
Sector: Disruptive Technology

Value Payment Systems provides electronic payment products and services to various payment industries including government and property management. The Company’s comprehensive e-payment service includes a wide array of payment channels including Internet and phone as well as emerging payment methods such as PINless debit.

visit website

Vets First Choice

Fund: Legacy
Sector: Animal Health

Vets First Choice offers a turn-key marketing service that allows veterinarians to regain control of the prescription products aspect of the client relationship. The company provides convenient online ordering, marketing, and support to help their clients provide exceptional service to customers.

visit website